about
Heat shock protein 10 and signal transduction: a "capsula eburnea" of carcinogenesis?Thyroid Hormones as Renal Cell Cancer RegulatorsCurrent approaches in identification and isolation of human renal cell carcinoma cancer stem cellsInsulin and IGFs in renal cancer risk and progressionFrontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinomaVitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approaches (review)Biology of renal tumour cancer stem cells applied in medicineChoosing the right cell line for renal cell cancer researchComparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer CellsMechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: A review of the literature.The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Molecular oncology focus - is carcinogenesis a 'mitochondriopathy'?Laryngeal embryonal rhabdomyosarcoma in an adult - a case presentation in the eyes of geneticists and clinicians.Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell CarcinomaTracheal adenoid cystic carcinoma mimicking a thyroid tumor: A case report.Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma.Metastasis-Initiating Cells in Renal Cancer.Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)Mitochondrial genotype in vulvar carcinoma - cuckoo in the nestThe role of the mitochondrial genome in ageing and carcinogenesis.Renal cell carcinoma with intramyocardial metastasesThe role of the cell-cell interactions in cancer progression.Rhabdomyosarcoma of the head and neck in childrenImpaired glucose metabolism treatment and carcinogenesis.Insulin-like growth factor-1 signaling in renal cell carcinomaAggressive osteoblastoma of the sphenoid bone.Functional significance of CD105-positive cells in papillary renal cell carcinoma.The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.Long-term parental satisfaction with adenotonsillectomy: a population study.Mitochondrial DNA mutations in human neoplasia.The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review.Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancerMitochondrial chaperones in cancer: from molecular biology to clinical diagnostics.Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarctionBreast cancer as a mitochondrial disorder (Review).Common mitochondrial polymorphisms as risk factor for endometrial cancer.Mitochondrial DNA mutations in cancer--from bench to bedside.Vulvar cancer as a target for molecular medicine.Ovarian cancer as a genetic disease.Hsp60 and human aging: Les liaisons dangereuses.
P50
Q24679824-AEAF5E87-0516-46BD-A24F-627614687579Q26748991-8CC66327-EB0C-417C-AE8F-38E45DA64465Q26786047-B1EC988B-E57A-4F9B-ABA5-F6BE624D6028Q26795424-C9A0A0DC-847C-40FB-BB3B-5AFF520F4902Q26863402-76183776-4F6B-4DDF-88C9-D5607B8B0722Q26992050-1E5214BC-1493-46E6-AA59-878F264754ACQ27004622-0E746ED9-9DE9-460E-9A95-1B939C5A3B64Q28073283-C206FFC4-5C34-484F-83CD-6EF24D6640BEQ28553202-4329F8E0-249F-4D92-B769-D82A9DD02CA1Q30244471-3DA8F29D-EF68-4C6F-9AE3-BDB8F4C5CDE3Q33623423-A5FB559C-5F1F-4BD0-ADE9-C6021FB517CFQ33875611-DC9CF614-9109-401D-B62A-B3FE038576DEQ33898857-3E749932-4D86-4857-8F54-C3716706689EQ33947929-3CFD04B9-9523-4B06-A3CD-CDA6A4EDBCDDQ33967730-F426FDE6-0FB3-4F77-977E-C5E76B77F4ACQ34077263-70A4E484-2961-46F3-849C-4A8618BCB1C2Q34077268-48614588-534C-4E37-9779-E9DA41D90F53Q34077272-EDFA1DE5-4B82-4D79-AE18-DB7EF159C88DQ34149398-AA1E8015-2975-491F-A5D5-84B254ECAA58Q34591630-FD0AECA8-E064-4E1F-B072-AC5CA266F9C1Q35240289-D81CE2B1-0FC2-49CE-A29D-E03FA4E40C2BQ35531372-3DC408A1-3164-43BE-A854-A53A1A706361Q35648994-3FBD1BD5-A407-4228-8F90-AE7C3D6C00ADQ35870409-085AE355-DEB9-4900-A203-B740028188DBQ36074111-E6742796-BE51-4DE3-A6C1-FD2D6BD25BC2Q36216756-8D9E638A-96C5-4EFC-A66E-98043259A058Q36241043-C1D1493E-47AD-4FBE-B87A-0DA9F4C051D6Q36300487-E4FD769A-3B7D-432F-9A3B-EB0A9C2EA6EEQ36327835-B3542192-F04E-4D41-BB89-C638A2321CF2Q36373045-4DE84A84-E4B9-4BA3-A569-6854456444E9Q36439447-A76E5B26-FBAC-427C-B588-85FAE4474BD1Q36524171-7C1FC84A-CC18-4235-A8E7-EF3A8DBC9CBFQ36544370-B8E31317-BEEC-4AE5-8116-A82CD811B762Q37093995-DCC70551-F219-47CD-AFD7-03FA67B49642Q37415390-6F83C165-9750-4192-AF35-1E4890B7EC0DQ37415903-5AB55D24-105C-46F2-9134-0F880639B71BQ37663208-E1360227-FD86-4B69-BEE6-AD03E17A770EQ37825291-30C7E907-23A6-431D-892B-66C2E0358DD2Q38070506-33E072EB-ABF0-4242-9670-859A9C4219CAQ38070510-A9C80988-77ED-4714-A8D1-E20EEFB4B3B9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Anna M Czarnecka
@ast
Anna M Czarnecka
@en
Anna M Czarnecka
@es
Anna M Czarnecka
@nl
Anna M Czarnecka
@sl
type
label
Anna M Czarnecka
@ast
Anna M Czarnecka
@en
Anna M Czarnecka
@es
Anna M Czarnecka
@nl
Anna M Czarnecka
@sl
altLabel
Anna M. Czarnecka
@en
prefLabel
Anna M Czarnecka
@ast
Anna M Czarnecka
@en
Anna M Czarnecka
@es
Anna M Czarnecka
@nl
Anna M Czarnecka
@sl
P214
P106
P21
P214
P31
P496
0000-0002-2107-3810
P735
P7859
viaf-316019538